Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

2008, Volume 15, Issue 02, pages 57-112

IN BRIEF
Br J Cardiol 2008;15:71

In brief

News in brief from the world of...

Read More

BOOK REVIEW
Br J Cardiol 2008;15:73-4

Echocardiography

Echocardiography: Oxford specialist handbook in cardiology is an invaluable tool in the diagnosis and management of patients with cardiac disease. This new Oxford Handbook is...

Read More

BOOK REVIEW
Br J Cardiol 2008;15:75

Handbook of cardiac electrophysiology

This handbook is a comprehensive and practical overview of all aspects of electrophysiology. It covers fundamentals such as the set-up of an electrophysiology laboratory and...

Read More

OBLIQUE VIEW
Br J Cardiol 2008;15:76–7

Tune in and turn off

We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab… and beyond. In this...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:79–81

Familial hypercholesterolaemia: recognising the unrecognised

Familial hypercholesterolaemia is a common genetic disorder that remains under-recognised. At present a simple genetic test is not available, although targeted genetic screening is being...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:83-85

Low-density lipoprotein-apheresis: an update

Low-density lipoprotein (LDL)-apheresis is the treatment of choice in homozygous familial hypercholesterolaemia as well as various other severe dyslipidaemic conditions. However, it appears to be...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:87-94

New anticoagulant strategies in ST-elevation myocardial infarction treated with fibrinolytic therapy

Anticoagulant therapy plays a key role in pharmacological reperfusion therapy for acute ST segment elevation myocardial infarction (STEMI). Until recently, the established role of unfractionated...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:95-100

A UK survey of rosuvastatin in general practice: reaching cholesterol targets

Data from 101 practices that had completed a survey of cholesterol target achievement using rosuvastatin in routine general practice were pooled to assess effectiveness at...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:101-5

A budget impact model for a drug in heart failure: eplerenone

The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) showed that addition of eplerenone to optimal medical therapy reduced morbidity and mortality...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:106-9

Effect of ivabradine, a novel anti-anginal agent, on heart rate and symptom control: a first experience in a clinical ‘real-world’ setting

Achieving a lower heart rate is important in treating angina. Established approaches include the use of beta blockers and certain calcium channel blockers. However, the...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:110

Surgery for palpitations?

A 63-year-old gentleman presented with palpitations and a sensation of chest fullness. He had previously undergone laparoscopic oesophageal...

Read More

EDITORIAL
Br J Cardiol 2008;15:63-4

Another NICE chapter in interventional cardiology: but it’s time for responsible debate

So now we know ... drug-eluting stents (DES) are not to vanish from our armoury at the whim of a National Institute for Health and...

Read More

EDITORIAL
Br J Cardiol 2008;15:65-6

Rosiglitazone and pioglitazone – where do we go from here?

In recent years, general practitioners (GPs) have been swamped by the burden of diabetes in the UK. The incidence has been growing almost as fast...

Read More

NEWS
Br J Cardiol 2008;15:68-9

NICE issues new draft guidance on drug-eluting stents

The National Institute for Health and Clinical Excellence (NICE) has recommended that drug-eluting stents can continue to be used in patients who have a higher...

Read More

NEWS
Br J Cardiol 2008;15:68-9

Questions raised on very intensive glucose lowering in type 2 diabetes

The results of two major trials of intensive glucose lowering in patients with type 2 diabetes appear to have reached different...

Read More

CLINICAL ARTICLE
Br J Cardiol 2008;15:111–2

Percutaneous coronary intervention in dextrocardia

Dextrocardia is a rare anomaly with an estimated prevalence of about one in 10,000. The incidence of coronary artery disease is the same as in...

Read More

NEWS
Br J Cardiol 2008;15:68-9

ADVANCE shows no harm

In contrast, the ADVANCE study, has not shown any harm in its intensive treatment arm. In this trial, 11,140 high-risk patients with type 2 diabetes,...

Read More

NEWS
Br J Cardiol 2008;15:68-9

Cardiovascular mortality patterns in Europe

A new study has highlighted a changing pattern of cardiovascular mortality within Europe, and shows that while cardiovascular mortality rates are decreasing in general, Eastern...

Read More

Close

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

Close

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits